---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-000980"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T04:09:04.615004+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics effects 1-for-10 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective 12:01 a.m. ET on Jan 4, 2024; shares begin trading split-adjusted same day.
- Common stock CUSIP changed to 471871202; trading symbol remains JSPR.
- Warrants (JSPRW) adjusted: 10 pre-split warrants exercisable for 1 share at $115.00 exercise price.
- No fractional shares issued; cash in lieu paid based on Jan 3, 2024 closing price.
- Split approved by board on Dec 22, 2023, after stockholder authorization on Dec 15, 2023.

## SEC filing metadata
- accession: 0001213900-24-000980
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/0001213900-24-000980-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/ea191024-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-000980
- JSON: https://secwatch.observer/filing/0001213900-24-000980.json
- Plain text: https://secwatch.observer/filing/0001213900-24-000980.txt

## Key facts
- Governance Changes
  Jasper Therapeutics, Inc.: Effected a 1-for-10 reverse stock split to regain compliance with Nasdaq minimum bid price requirement (effective 2024-01-04).
  - Change: charter amendment
  - Effective: 2024-01-04
  source text: The Reverse Stock Split was effective at 12:01 a.m., Eastern Time, on January 4, 2024, and the Common Stock is expected to begin trading on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market at the opening of the market on January 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/0001213900-24-000980-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.